Recent Updates
Recently added Catalysts
ACAD Positive Sentiment

Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference

Key Takeaway: Acadia Pharmaceuticals Inc. has announced its participation in the Canaccord Genuity 46th Annual Growth Conference. The event is scheduled for August 12, 2026, at 1:30 p.m. Eastern Time. Investors can access live webcasts on the company's website, with recordings available for a month post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Acadia Pharmaceuticals is actively engaging with investors.
  • Participation in a reputable conference highlights company visibility.
  • Live webcasts provide transparency and accessibility for stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+12%
120-day peak, hindsight
Typical move
5.6%
average across 7 past catalysts
Lead asset
ACP-044 Dose A
Phase 2 · Acute Postoperative Pain

Full Press Release Details

WARSAW, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the Canaccord Genuity 46thAnnual Growth Conference, held in Boston, MA.

Event:Canaccord Genuity 46thAnnual Growth ConferenceFormat:Fireside ChatDate:Wednesday, August 12, 2026Time:9:00 am ET

An audio webcast of the discussion will be available online at the OrthoPediatrics’ investor relations website,http://ir.orthopediatrics.com. Additionally, a replay will be available after the event.
About OrthoPediatrics Corp.Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visitwww.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visitwww.opsb.com.

Investor ContactPhilip Trip TaylorGilmartin Groupphilip@gilmartinir.com415-937-5406

Frequently Asked Questions

When will Acadia participate in the conference?

Acadia will participate on August 12, 2026, at 1:30 p.m. Eastern Time.

Where can I watch the live webcast?

The live webcasts will be available on Acadia's website under the investors section.

How long will the archived recording be available?

The archived recording will be accessible for approximately one month after the presentation.

Last updated: Jul 30, 2026